<DOC>
	<DOCNO>NCT02797847</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability , pharmacokinetics pharmacodynamics ALN-TTRSC02 healthy subject .</brief_summary>
	<brief_title>A Safety Tolerability Study Investigational Drug , ALN-TTRSC02 , Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Amyloidosis</mesh_term>
	<criteria>Male female subject , age 18 65 year , inclusive . Body mass index ( BMI ) ≥18.0 kg/m2 ≤30 kg/m2 assess Screening . No clinically significant health concern , determine medical history physical examination , opinion Investigator . Women child bear potential must negative pregnancy test , breastfeeding , must willing use contraception , willing able comply study requirement provide write informed consent . For Japanese cohort , subject Japanese descent define people carry Japanese passport , descendants 4 Japanese grandparent , outside Japan 5 year . Clinically relevant history presence respiratory , gastrointestinal , renal , cardiovascular , hepatic , hematological , lymphatic , neurological , psychiatric , musculoskeletal , genitourinary , immunological , inflammatory disease , dermatological connective tissue diseases disorder . Active serious mental illness psychiatric disorder . Clinically significant ECG abnormality . Abnormal AST/ALT clinical safety laboratory result consider clinically significant . Known history allergic reaction oligonucleotide GalNAc . History intolerance subcutaneous injection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>TTR-mediated Amyloidosis</keyword>
	<keyword>Amyloidosis , Hereditary</keyword>
	<keyword>Amyloid Neuropathies , Familial</keyword>
	<keyword>Familial Amyloid Polyneuropathies</keyword>
	<keyword>Amyloid Neuropathies</keyword>
	<keyword>Amyloidosis , Hereditary , Transthyretin-Related</keyword>
	<keyword>Familial Amyloidosis</keyword>
	<keyword>RNAi therapeutic</keyword>
</DOC>